SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-060672
Filing Date
2014-10-10
Accepted
2014-10-10 16:31:52
Documents
7
Period of Report
2014-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v390943_8k.htm 8-K 21790
2 EXHIBIT 4.1 v390943_ex4-1.htm EX-4.1 89202
3 EXHIBIT 5.1 v390943_ex5-1.htm EX-5.1 8373
4 EXHIBIT 10.1 v390943_ex10-1.htm EX-10.1 60710
5 EXHIBIT 10.2 v390943_ex10-2.htm EX-10.2 12250
6 EXHIBIT 99.1 v390943_ex99-1.htm EX-99.1 13254
7 GRAPHIC tlogo.jpg GRAPHIC 9244
  Complete submission text file 0001144204-14-060672.txt   219651
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 141152721
SIC: 2834 Pharmaceutical Preparations